- £2.66m
- £2.47m
- £0.61m
REG - IQ-AI Limited - IB Opens Expanded Access Program
AnnouncementREG - IQ-AI Limited - Clinical Trial Updates
AnnouncementREG - IQ-AI Limited - Result of AGM
AnnouncementREG - IQ-AI Limited - Major East Coast Health System Chooses IB Nimble
AnnouncementREG - IQ-AI Limited - Second FDA Rare Pediatric Disease Designation
AnnouncementREG - IQ-AI Limited - IB Software Enhances Clinical Decision-Making
AnnouncementREG - IQ-AI Limited - Rare Pediatric Disease Designation Granted to GaM
AnnouncementREG - IQ-AI Limited - IB Announces Expanded Access Program for GaM
AnnouncementREG - IQ-AI Limited - Publication of Annual Report
AnnouncementREG - IQ-AI Limited - Grant of Options
AnnouncementREG - IQ-AI Limited - Holding(s) in Company
AnnouncementREG - IQ-AI Limited - Holding(s) in Company
AnnouncementREG - IQ-AI Limited - Result of Broker Option and Total Voting Rights
AnnouncementREG - IQ-AI Limited - Placing and Broker Option
AnnouncementREG - IQ-AI Limited - FDA Application Update
AnnouncementREG - IQ-AI Limited - IB awarded a $100,000 grant
AnnouncementREG - IQ-AI Limited - Holding(s) in Company
AnnouncementREG - Stock Exch Notice - Admission to Trading - 19/01/2024
AnnouncementREG - Official List - Official List Notice
Announcement